http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005536529-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate | 2003-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005536529-A |
| titleOfInvention | Antitumor analogs of lamellarins |
| abstract | Formula III: [Formula 1] Wherein X is selected from the group consisting of N, O and S; wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are , H, OH, OR ′, SH, SR ′, SO 2 R ′, NHR ′, N (R ′) 2 , N = R ′, NHCOR ′, N (COR ′) 2 , NHSO 2 R ′, NO 2 , PO (R ′) 2 , PO 2 R ′, C (═O) H, C (═O) R ′, CO 2 H, CO 2 R ′, OPO (R ′) 2 , OPO 2 R ′, OC (═O) H, OC (═O) R ′, N═C (R ′) 2 , substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 haloalkyl, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted aralkyl, and substituted Or selected from the group consisting of unsubstituted heteroaromatic groups; wherein each R ′ group is independently H, OH, NO 2 , NH 2 , SH, CN, halogen, ═O, C (= O) H, C (= O ) CH 3, CO 2 H, C (= O) R ', substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 2 -C 18 alkenyl, substituted or unsubstituted C 2 -C 18 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted C 1 -C 18 alkoxyl, substituted or unsubstituted C 1 -C 18 aminoalkyl, substituted or unsubstituted C 1 ~ C 18 amino acid, a substituted or unsubstituted C 1 -C 18 thioalkyl, substituted or unsubstituted C 1 -C 18 alkylsulfinyl, is selected from the group consisting of C 1 -C 18 alkylsulfonyl substituted or unsubstituted; wherein , R 1 and R 2 , R 2 and R 3 , R 3 and R 4 , R 3 and R 9 , R 4 and R 9 , R 9 and R 5 , R 9 and R 6 , R 6 and R 7 , R 7 and R 8 A group of groups can be incorporated into a carbocyclic or heterocyclic system; and the dotted line represents a single bond or a double bond.) Or a pharmaceutically acceptable salt, derivative, prodrug, or stereoisomer thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5888702-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012099129-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013500307-A |
| priorityDate | 2002-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 217.